This September, Pharma Tech Outlook included Flex Databases in Top-10 Pharmacovigilance solutions providers in the UK & Europe.
Our Business Development & Marketing Director Evgenia Mikhalchuk took part in a cover story for Pharma Tech Outlook September’22 issue, supporting our nomination:
Clinical trials have always been about data. But, prior to automation, data input was a major concern.
For us, it is crucial to concentrate on whether the data is actually functional for everyone while also ensuring that its consumption is as simple as breathing.
The company’s software solution is based on materialising this expression and providing a system for clinical trials that is automated, uncomplicated, and ensures compliant pharmacovigilance activities throughout all the trial stages. A highly comprehensive, flexible, and intuitive solution, the tool enables its users to meet the rapidly evolving requirements of clinical investigation, catalysing the trials’ progress swiftly.
To perform multi-fold tasks, including data collection and assessments in clinical trials, Flex Databases facilitates a BI (Business Intelligence) reporting tool that is designed to provide instant data accessibility for further interpretations and actions. The tool eliminates labor-intensive, repetitive data inputs required in performing critical undertakings such as planning and reporting. Additionally, it empowers clinical research enterprises with insights to gain increased visibility into study progress.
Our software solution is based on materialising this expression and providing a system for clinical trials that is automated, uncomplicated, and ensures compliant pharmacovigilance activities throughout all the trial stages. A highly comprehensive, flexible, and intuitive solution, the tool enables its users to meet the rapidly evolving requirements of clinical investigation, catalysing the trials’ progress swiftly.
The company’s software solution is based on materializing this expression and providing a system for clinical trials that is automated, uncomplicated, and ensures compliant pharmacovigilance activities throughout all the trial stages. A highly comprehensive, flexible, and intuitive solution, the tool enables its users to meet the rapidly evolving requirements of clinical investigation, catalyzing the trials’ progress swiftly.
The company stands out distinctively in its approach to handling its clients’ clinical data management concerns earnestly, facilitating a transparent collaboration with them. It helped one of its clients in the research of COVID vaccines during the compelling times of the pandemic. The research required the integration of several data sets into Flex’s architecture while maintaining the system’s performance for search, analysis, and signal detection. Interestingly, during the course of this engagement, Flex Databases successfully aggregated hundreds of thousands of cases within its analysis system without hampering the efficiency of results obtained. The company demonstrated exception resilience and readiness through its solutions, especially during the testing times of the pandemic.
To read the full interview and explore Flex Databases profile, you can either download the pdf-version of the story, view it on Pharma Tech Outlook website or get a printed out version.
